Following graduation from the Humboldt University Medical School in Berlin, Germany, Andreas Meisel went on to become an EMBO fellow at the Biocenter, University of Basel, Switzerland.

He is currently Professor of Neurology and Senior Physician at the Department of Neurology with Experimental Neurology and NeuroCure Clinical Research Center, and serves as Director of the Center for Stroke Research Berlin.

He is also Head of the Integrated Myasthenia Gravis Center at the Charité Universitätsmedizin in Berlin, and chairman of the Medical Advisory Board of the German Myasthenia Society and Head of the Berlin Stroke Alliance.

Professor Meisel is engaged in experimental and clinical research, with a primary focus in neuromuscular and cerebrovascular disorders. The aim of this research is to identify and establish novel treatment strategies and biomarkers for individualised decision-making in patient care.

Professor Wiendl studied medicine in Germany, Switzerland, and the USA, graduating in 1996. After working as a research fellow at the Institute of Neuroanatomy, Nuremberg, and the Max Planck Institute for Neurobiology and the Department of Neurology, Tuebingen, he became head of the clinical research group for multiple sclerosis (MS) in Wuerzburg in 2005 and acted as a vice-chair of the Department of Neurology.

In 2010, he was recruited to Muenster University Hospital as director of the Department of Neurology – Inflammatory Disorders of the Nervous System and Neurooncology. Since 2013, he serves as head of the Department of Neurology, Muenster – to which the Institute of Translational Neurology has been associated since 2018.

His research focusses on inflammatory neurodegeneration and immune regulation and protection as well as monitoring MS and its therapy. His achievements have been recognized by both Sobek awards of the German Society for MS (DMSG) (2004; 2015). In 2017, Heinz Wiendl was appointed Honorary Professor at Sydney Medical School. Masshad University awarded him the title of Honorary Doctor and Honorary Professor in 2021.

Professor Wiendl is a member of numerous scientific and academic advisory boards and expert panels, including editorial boards of international scientific journals in the fields of neurology, neurosciences, and immunology, as well as for societies, foundations, and project promoters. Currently, he is the speaker of the Collaborative Research Center 128 "Multiple Sclerosis", and speaker of the competence network Multiple Sclerosis (KKNMS).

Furthermore, he was appointed fellow of the American and the European Academy of Neurology in 2019. Until 2016, Heinz Wiendl was Vice Dean for Research of the Medical Faculty in Muenster. He is founder and principal investigator of the "Body and Brain Institute" Muenster, a prestigious research building funded by the German Federal Ministry.

Professor Wiendl served as a PI for or coordinated through membership of steering committees ≥40 phase I-IV clinical trials. Since 1998, he has authored more than 650 peer-reviewed publications in high-impact journals such as Nature Medicine, Journal of Experimental Medicine, Blood, Annals of Neurology, BRAIN, Neurology, Nature Neuroscience, Immunity (H index = 77, approx. 1,500 citations/year), 4 books (editor), several book chapters.